NEW YORK, Nov 6 (Reuters) - Shares of Boston Scientific fell 3.1 percent to $7.80 in premarket trading on Friday, after the company reached an agreement with the U.S. Department of Justice related to product recalls issued by its Guidant subsidiary.
The company also said it would record a third-quarter charge of $294 million.
For details, see

(Reporting by Ryan Vlastelica; Editing by James Dalgleish) Keywords: MARKETS STOCKS BEFORETHEBELL (ryan.vlastelica@thomsonreuters.com; Tel: +1 646-223-6014; Reuters Messaging: ryan.vlastelica@reuters.com@reuters.net)

COPYRIGHT

Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.